Engineers Gate Manager LP

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1620220 NEW YORK, NY

Position in FULC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$885,720

-$81,536 QoQ

Shares Held

242,000

+91.9% QoQ

Ownership

0.317%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#42

of 154 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names. FULC ranks #61 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$885,720	242,000	+91.9%	Shares	Sole	2026-08-14
2026-03-31	$967,256	126,109	+907.3%	Shares	Sole	2026-05-15
2025-03-31	$36,054	12,519	-50.4%	Shares	Sole	2025-05-15
2024-09-30	$90,085	25,234	+27.1%	Shares	Sole	2024-11-14
2024-06-30	$123,132	19,860	-33.4%	Shares	Sole	2024-08-14
2023-03-31	$84,992	29,822	+39.6%	Shares	Sole	2023-05-15
2022-06-30	$104,644	21,356	+81.4%	Shares	Sole	2022-08-15
2021-06-30	$123,381	11,773	-31.3%	Shares	Sole	2021-08-16
2021-03-31	$201,956	17,144	-13.5%	Shares	Sole	2021-05-17
2020-12-31	$231,986	19,811	-1.5%	Shares	Sole	2021-02-16
2020-09-30	$159,432	20,105	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.